Ashwagandha root extract improves sleep quality in pregnant women
In a 12-week RCT, Ashwagandha root extract (ARE) 300 mg twice daily plus standard care significantly improved subjective sleep quality at all visits (p=0.036), sleep duration at weeks 8 and 12 (p<0.001), and sleep disturbances at week 12 (p=0.028) compared to standard care alone in pregnant women in their second trimester. No adverse events were reported.
Evidence Score
Study Evidence
Study 1. Efficacy and safety of Ashwagandha (Withania somnifera) root extract in pregnant women: a prospective, randomized, comparative, open-label, 12-week study.
observationalAjgaonkar A, Tayade H, Nayak A ยท Frontiers in global women's health (2026)
Result:
Mechanism Graph
Limitations
- โ Open-label design may introduce bias
- โ Small sample size (n=70) limits generalizability
- โ Sleep outcomes were secondary endpoints, not primary focus
Frequently Asked Questions
Is Ashwagandha safe to take during pregnancy?โผ
In this 12-week study, no adverse events or serious adverse events were reported, and liver, kidney, and thyroid function remained stable, suggesting short-term safety in the second trimester.
How much Ashwagandha was given to improve sleep?โผ
Participants received 300 mg of Ashwagandha root extract twice daily (total 600 mg per day) for 12 weeks.
What sleep improvements were seen with Ashwagandha?โผ
Significant improvements were observed in subjective sleep quality at all visits, sleep duration at weeks 8 and 12, and sleep disturbances at week 12.
Did Ashwagandha also help with stress in pregnant women?โผ
Yes, perceived stress scores reduced significantly more in the Ashwagandha group (-10.50) compared to standard care (-5.35) at week 12 (p<0.001).
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Ajgaonkar A, Tayade H, Nayak A. "Efficacy and safety of Ashwagandha (Withania somnifera) root extract in pregnant women: a prospective, randomized, comparative, open-label, 12-week study.." Frontiers in global women's health, 2026. PMID: 41767760 DOI: 10.3389/fgwh.2026.1767865